Supplements
Human trials link bovine colostrum to lower gut permeability, fewer respiratory symptoms in hard-training athletes and modest lean-mass gains. The doses used, the limits and the safety picture.
Key takeaways
Colostrum — the first milk produced by mammals in the days after birth — has been used medicinally for centuries. But the recent wave of interest isn’t nostalgia. It’s backed by a growing body of human clinical trials showing measurable effects on gut permeability, immune function, respiratory infections, and athletic recovery.
Bovine colostrum (from cows) is bioavailable to humans, commercially available, and comparably potent to human colostrum for most bioactive compounds. This article covers what the evidence actually shows, who benefits most, and how to dose it.
Colostrum is the nutrient-dense fluid secreted by mammary glands during the first 24–72 hours postpartum — before transitional milk production begins. Unlike mature milk, colostrum is low in fat and lactose and extremely high in:
Bovine colostrum contains far more IgG than mature milk (on the order of 100× or more). It’s collected from dairy herds in the first 24–48 hours after calving, pasteurized at low temperatures to preserve bioactives, and freeze-dried into powder form.
The most compelling and consistent finding across human trials is colostrum’s ability to reduce intestinal permeability — what’s colloquially called “leaky gut.”
Playford et al. (2001) published a landmark placebo-controlled trial in Gut showing that bovine colostrum (20g/day) significantly reduced gut permeability induced by NSAIDs (indomethacin) in healthy volunteers. Lactulose/rhamnose ratio — the gold standard permeability marker — was reduced by approximately 60% compared to placebo. This was the first rigorous human demonstration that oral colostrum has direct GI effects after being consumed, not just activity in the infant gut.
Marchbank et al. (2011) found that 20g/day of bovine colostrum for 14 days blunted the rise in gut permeability caused by heavy exercise in athletes on lactulose/rhamnose permeability measures. The dose required was remarkably low.
For athletes specifically — who experience well-documented exercise-induced gut permeability increases (particularly in endurance sports) — Davison et al. (2016) found that 500mg/day of colostrum reduced exercise-induced increases in plasma endotoxin (LPS) by approximately 50% compared to whey protein placebo. This is significant: elevated circulating LPS from gut permeability triggers systemic inflammation and impairs recovery.
The mechanism: Growth factors in colostrum (particularly TGF-β and EGF) stimulate enterocyte proliferation and tighten the tight junction proteins (occludin, claudin-1) that govern paracellular permeability. Colostrum also supports mucus layer thickness, which buffers the epithelium from luminal contents.
A second major evidence base centers on colostrum’s immunoglobulins providing passive immune support — essentially oral passive immunotherapy.
Cesarone et al. (2007), published in Clinical and Applied Thrombosis/Hemostasis, randomized 144 subjects over 12 weeks to either seasonal flu vaccination alone, colostrum (400mg/day) alone, colostrum + vaccination, or vaccination + whey protein. Results: the colostrum groups had roughly one-third as many days with flu-like illness as vaccination alone (the paper reports 3× more flu days in subjects not taking colostrum). Combined colostrum + vaccination showed additive benefit. This was a single, non-blinded study; it is not a reason to skip vaccination.
Mero et al. (2002) conducted a double-blind, placebo-controlled crossover trial in elite cyclists and found that 10g/day of colostrum over 8 weeks was associated with fewer self-reported upper-respiratory symptoms than whey protein. This has been replicated in other high-intensity athlete populations.
Crooks et al. (2010) found that colostrum supplementation during a 12-week intense exercise block reduced salivary IgA decline (a marker of mucosal immune suppression common in overtraining) compared to whey protein placebo.
The proposed mechanism: oral IgG and IgA from colostrum bind pathogens in the gut lumen and nasopharynx, providing localized passive immunity. In laboratory studies lactoferrin interferes with cell entry of several viruses (including influenza and RSV); this has not been shown to prevent infection in people.
Colostrum is not a systemic immune booster in the way that high-dose vitamin C or zinc supplementation might theoretically be. The immunoglobulins are partially degraded by stomach acid before reaching the gut — enteric-coated formulations may improve delivery but evidence is mixed. Colostrum doesn’t meaningfully raise serum IgG levels (it’s not absorbed intact at therapeutic concentrations). Its immune benefit appears to be primarily local — mucosal immunity in the gut and respiratory tract.
The colostrum-performance literature is one of the more interesting bodies of research in sports supplementation.
Antonio et al. (2001) ran an 8-week trial in active men and women (20g/day colostrum vs. whey) and reported a greater gain in bone-free lean mass in the colostrum group, without a performance difference and time trial performance. The colostrum group gained ~1.8% more lean mass and reduced total time trial performance by ~6 seconds (p<0.05).
Brinkworth and Buckley (2002) randomized 51 active men and women to colostrum vs. whey protein for 8 weeks of resistance training. Colostrum group showed significantly greater gains in lean body mass (+2.11 kg vs. +1.26 kg) and sprint power.
The performance mechanism isn’t fully established but likely involves multiple pathways:
Important caveat: Most colostrum-performance trials compare it to whey protein, not placebo. Some trials show colostrum is significantly better than whey; others show equivalence. The honest summary: colostrum appears at least as good as whey protein for body composition and recovery, with additional gut and immune benefits not provided by whey.
Bovine colostrum contains IGF-1. Oral IGF-1 is largely degraded before systemic absorption, but studies show modest serum IGF-1 elevations with high-dose colostrum (>20g/day).
WADA status: Colostrum is not on WADA’s prohibited list and is not prohibited in competition. However, the hormone and related substances panel may flag elevated IGF-1 in biological passport programs. Competitive athletes subject to anti-doping controls should be aware of this and consult their governing body. This caveat is essentially absent from most supplement coverage — Examine.com notes it briefly; most other sources ignore it.
Clinical trials span a wide dose range, but most human studies used:
| Purpose | Dose | Duration |
|---|---|---|
| Gut permeability / NSAID protection | 2.5–20g/day | 2–8 weeks |
| Upper-respiratory symptom trials (athletes) | 400mg–10g/day | 8–12 weeks |
| Athletic performance / lean mass | 20g/day | 8 weeks |
Form: Powdered bovine colostrum is the most studied form. Products should specify: IgG content by percentage (look for ≥25% IgG), collection timing (first 6–12 hours is optimal for higher immunoglobulin density), and processing method (low-temperature pasteurization preserves bioactives).
Timing: No strong evidence for specific timing. Taking with food may buffer stomach acid and preserve more immunoglobulins, though the degradation question is partly moot — even partially degraded fractions appear bioactive in the gut.
Enteric coating: Some manufacturers offer enteric-coated capsules to deliver intact IgG past the stomach. Theoretically sound, but human trial evidence specifically for enteric-coated colostrum vs. standard powder is sparse.
Bovine colostrum has an excellent safety profile in all published human trials. Key considerations:
Dairy allergy: Colostrum contains casein and whey proteins. People with true IgE-mediated dairy allergy should avoid it. Lactose intolerance is generally not a concern — commercial colostrum is very low in lactose.
Immunocompromised individuals: Counterintuitively, immunostimulatory supplements warrant caution in autoimmune conditions. PRP peptides in colostrum can modulate cytokine responses in both directions (up-regulating underactive immune responses, down-regulating excessive ones), but clinical data in autoimmune populations is thin.
Pregnancy/breastfeeding: No specific human safety data; conventional caution applies.
Contamination risk: As an animal-derived product, colostrum sourced from herds using antibiotics or hormones is a concern. Look for products from pasture-raised herds with third-party testing.
Drug interactions: No established interactions. Theoretical concern for additive effect with immunosuppressant drugs — consult a physician if on biologics or immunosuppression.
| Supplement | Mechanism | Gut Permeability Evidence | GI Pathogen Protection |
|---|---|---|---|
| Bovine Colostrum | Growth factors, IgG, lactoferrin | Strong (multiple RCTs) | Strong (IgG, lactoferrin) |
| L-Glutamine | Enterocyte fuel source | Moderate | Minimal |
| Zinc | Tight junction upregulation | Moderate | Minimal |
| Probiotics | Competitive exclusion, short-chain fatty acids | Variable (strain-dependent) | Good for specific strains |
| Bone Broth | Collagen peptides, glutamine | Weak (low-quality evidence) | None |
| Quercetin | Claudin/occludin expression | Preclinical mainly | None |
Colostrum is unique in combining structural repair (growth factors), immune defense (IgG), and antimicrobial activity (lactoferrin) in a single supplement — a profile no other gut health supplement matches.
Strong candidates: - Athletes with high training loads (especially endurance athletes) experiencing frequent upper respiratory infections - Anyone with NSAID use and GI sensitivity - People with NSAID- or exercise-related gut symptoms, after discussing it with a clinician - Those who get frequent colds or respiratory infections in high-exposure environments
Moderate candidates: - People optimizing body composition who want whey protein with additional gut and immune benefits - Anyone with gut dysbiosis or ongoing low-grade GI inflammation
Lower priority: - Generally healthy individuals with no gut symptoms and low infection frequency — the cost-benefit ratio is less favorable - Competitive athletes subject to strict anti-doping testing (consult governing body before use)
Bovine colostrum is one of the few supplements with consistent human RCT evidence across multiple domains: trials report reduced gut-permeability markers, fewer self-reported upper-respiratory symptoms in athletes, and modest body-composition effects at least comparable to whey protein.
The evidence is not universally strong — performance trials have methodological limitations, the IGF-1 absorption question is unresolved, and optimal dosing isn’t precisely established. But compared to most supplements marketed for gut health and immunity, colostrum’s evidence base is substantially better.
For high-volume athletes, frequent travelers, or anyone dealing with gut permeability issues, it’s among the most evidence-supported options available.
This article is for general education and is not medical advice.
Sources: Playford et al. 2001, Clin Sci | Marchbank et al. 2011, Am J Physiol Gastrointest Liver Physiol | Cesarone et al. 2007, Clin Appl Thromb Hemost | Brinkworth & Buckley 2003, Eur J Nutr | Antonio et al. 2001, Nutrition | Crooks et al. 2010, Int J Sport Nutr Exerc Metab
Related
Supplements
Three COSMOS sub-studies found a daily multivitamin nudged memory scores in adults over 60. How big the effect is, why an earlier trial found nothing, and where cancer, heart and lifespan data stand.
Supplements
Your endocannabinoid system helps regulate pain and inflammation. What reviews and surveys report about hemp-derived plant compounds, and where the evidence stops.
Supplements
Turkesterone has no human trials. Its cousin ecdysterone has a 10-week trial showing modest lean-mass gains and a later one showing none. Mechanism, study doses and the product-quality problem.
Readers
Comments
Leave a comment